Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects [Phase 1]

View source ↗

Summary

This document reports a Phase 1 clinical trial to assess safety, tolerability, and pharmacokinetics of DA-8010 in healthy subjects for overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• DA-8010

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Overactive Bladder | Phase 1 | Status: UNKNOWN